ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily
TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
5.42% | $3.82b |
🏋🏿♂️Weight Rank In ARKK | 🌏Country |
2 | 🇨🇭Switzerland |
🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
208 | $62.32 |
🎫ARK Ownership Percent | |
6.91% |
Other ETFs That Hold CRSP
Research Notes and Commentary for CRSP
No Research Notes Found for CRSP